Global Swine Mycoplasma Vaccine Market Research Report 2024

Publication ID:

PB508241279

Publication Date:

August 14, 2024

Pages:

101

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Agriculture [2]

Industry & Manufacturing [3]

Description:

Swine mycoplasma vaccine is a type of vaccine that is designed to prevent mycoplasma infections in pigs. Mycoplasmas are bacteria that can cause a variety of respiratory and reproductive diseases in pigs, such as enzootic pneumonia, arthritis, and urinary tract infections.
The global Swine Mycoplasma Vaccine market was valued at US$ 647 million in 2023 and is anticipated to reach US$ 1117.4 million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.
North American market for Swine Mycoplasma Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Swine Mycoplasma Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Swine Mycoplasma Vaccine include Zoetis, Boehringer Ingelheim, Jinhe Biotechnology, Merck, HIPRA, Ceva Sant茅 Animale, Harbin Pharmaceutical Group, Pulike Biotech and Qilu Animal Health Products, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Swine Mycoplasma Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Mycoplasma Vaccine.
Report Scope
The Swine Mycoplasma Vaccine market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Swine Mycoplasma Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Mycoplasma Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Boehringer Ingelheim
Jinhe Biotechnology
Merck
HIPRA
Ceva Sant茅 Animale
Harbin Pharmaceutical Group
Pulike Biotech
Qilu Animal Health Products
Wuhan Keqian Biology
Guangdong Winsun Bio-Pharmaceutical
Segment by Type
Inactivated Vaccines
Live Vaccines
Segment by Application
Piglets
Adult Pigs
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Swine Mycoplasma Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Swine Mycoplasma Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Swine Mycoplasma Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Swine Mycoplasma Vaccine Market Overview
1.1 Product Definition
1.2 Swine Mycoplasma Vaccine Segment by Type
1.2.1 Global Swine Mycoplasma Vaccine Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Inactivated Vaccines
1.2.3 Live Vaccines
1.3 Swine Mycoplasma Vaccine Segment by Application
1.3.1 Global Swine Mycoplasma Vaccine Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Piglets
1.3.3 Adult Pigs
1.4 Global Market Growth Prospects
1.4.1 Global Swine Mycoplasma Vaccine Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Swine Mycoplasma Vaccine Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Swine Mycoplasma Vaccine Production Estimates and Forecasts (2019-2030)
1.4.4 Global Swine Mycoplasma Vaccine Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Swine Mycoplasma Vaccine Production Market Share by Manufacturers (2019-2024)
2.2 Global Swine Mycoplasma Vaccine Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Swine Mycoplasma Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Swine Mycoplasma Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Swine Mycoplasma Vaccine Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Swine Mycoplasma Vaccine, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Swine Mycoplasma Vaccine, Product Offered and Application
2.8 Global Key Manufacturers of Swine Mycoplasma Vaccine, Date of Enter into This Industry
2.9 Swine Mycoplasma Vaccine Market Competitive Situation and Trends
2.9.1 Swine Mycoplasma Vaccine Market Concentration Rate
2.9.2 Global 5 and 10 Largest Swine Mycoplasma Vaccine Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Swine Mycoplasma Vaccine Production by Region
3.1 Global Swine Mycoplasma Vaccine Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Swine Mycoplasma Vaccine Production Value by Region (2019-2030)
3.2.1 Global Swine Mycoplasma Vaccine Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Swine Mycoplasma Vaccine by Region (2025-2030)
3.3 Global Swine Mycoplasma Vaccine Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Swine Mycoplasma Vaccine Production by Region (2019-2030)
3.4.1 Global Swine Mycoplasma Vaccine Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Swine Mycoplasma Vaccine by Region (2025-2030)
3.5 Global Swine Mycoplasma Vaccine Market Price Analysis by Region (2019-2024)
3.6 Global Swine Mycoplasma Vaccine Production and Value, Year-over-Year Growth
3.6.1 North America Swine Mycoplasma Vaccine Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Swine Mycoplasma Vaccine Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Swine Mycoplasma Vaccine Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Swine Mycoplasma Vaccine Production Value Estimates and Forecasts (2019-2030)
4 Swine Mycoplasma Vaccine Consumption by Region
4.1 Global Swine Mycoplasma Vaccine Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Swine Mycoplasma Vaccine Consumption by Region (2019-2030)
4.2.1 Global Swine Mycoplasma Vaccine Consumption by Region (2019-2024)
4.2.2 Global Swine Mycoplasma Vaccine Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Swine Mycoplasma Vaccine Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Swine Mycoplasma Vaccine Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Swine Mycoplasma Vaccine Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Swine Mycoplasma Vaccine Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Swine Mycoplasma Vaccine Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Swine Mycoplasma Vaccine Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Swine Mycoplasma Vaccine Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Swine Mycoplasma Vaccine Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Swine Mycoplasma Vaccine Production by Type (2019-2030)
5.1.1 Global Swine Mycoplasma Vaccine Production by Type (2019-2024)
5.1.2 Global Swine Mycoplasma Vaccine Production by Type (2025-2030)
5.1.3 Global Swine Mycoplasma Vaccine Production Market Share by Type (2019-2030)
5.2 Global Swine Mycoplasma Vaccine Production Value by Type (2019-2030)
5.2.1 Global Swine Mycoplasma Vaccine Production Value by Type (2019-2024)
5.2.2 Global Swine Mycoplasma Vaccine Production Value by Type (2025-2030)
5.2.3 Global Swine Mycoplasma Vaccine Production Value Market Share by Type (2019-2030)
5.3 Global Swine Mycoplasma Vaccine Price by Type (2019-2030)
6 Segment by Application
6.1 Global Swine Mycoplasma Vaccine Production by Application (2019-2030)
6.1.1 Global Swine Mycoplasma Vaccine Production by Application (2019-2024)
6.1.2 Global Swine Mycoplasma Vaccine Production by Application (2025-2030)
6.1.3 Global Swine Mycoplasma Vaccine Production Market Share by Application (2019-2030)
6.2 Global Swine Mycoplasma Vaccine Production Value by Application (2019-2030)
6.2.1 Global Swine Mycoplasma Vaccine Production Value by Application (2019-2024)
6.2.2 Global Swine Mycoplasma Vaccine Production Value by Application (2025-2030)
6.2.3 Global Swine Mycoplasma Vaccine Production Value Market Share by Application (2019-2030)
6.3 Global Swine Mycoplasma Vaccine Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Zoetis
7.1.1 Zoetis Swine Mycoplasma Vaccine Corporation Information
7.1.2 Zoetis Swine Mycoplasma Vaccine Product Portfolio
7.1.3 Zoetis Swine Mycoplasma Vaccine Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Zoetis Main Business and Markets Served
7.1.5 Zoetis Recent Developments/Updates
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Swine Mycoplasma Vaccine Corporation Information
7.2.2 Boehringer Ingelheim Swine Mycoplasma Vaccine Product Portfolio
7.2.3 Boehringer Ingelheim Swine Mycoplasma Vaccine Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Boehringer Ingelheim Main Business and Markets Served
7.2.5 Boehringer Ingelheim Recent Developments/Updates
7.3 Jinhe Biotechnology
7.3.1 Jinhe Biotechnology Swine Mycoplasma Vaccine Corporation Information
7.3.2 Jinhe Biotechnology Swine Mycoplasma Vaccine Product Portfolio
7.3.3 Jinhe Biotechnology Swine Mycoplasma Vaccine Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Jinhe Biotechnology Main Business and Markets Served
7.3.5 Jinhe Biotechnology Recent Developments/Updates
7.4 Merck
7.4.1 Merck Swine Mycoplasma Vaccine Corporation Information
7.4.2 Merck Swine Mycoplasma Vaccine Product Portfolio
7.4.3 Merck Swine Mycoplasma Vaccine Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Merck Main Business and Markets Served
7.4.5 Merck Recent Developments/Updates
7.5 HIPRA
7.5.1 HIPRA Swine Mycoplasma Vaccine Corporation Information
7.5.2 HIPRA Swine Mycoplasma Vaccine Product Portfolio
7.5.3 HIPRA Swine Mycoplasma Vaccine Production, Value, Price and Gross Margin (2019-2024)
7.5.4 HIPRA Main Business and Markets Served
7.5.5 HIPRA Recent Developments/Updates
7.6 Ceva Sant茅 Animale
7.6.1 Ceva Sant茅 Animale Swine Mycoplasma Vaccine Corporation Information
7.6.2 Ceva Sant茅 Animale Swine Mycoplasma Vaccine Product Portfolio
7.6.3 Ceva Sant茅 Animale Swine Mycoplasma Vaccine Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Ceva Sant茅 Animale Main Business and Markets Served
7.6.5 Ceva Sant茅 Animale Recent Developments/Updates
7.7 Harbin Pharmaceutical Group
7.7.1 Harbin Pharmaceutical Group Swine Mycoplasma Vaccine Corporation Information
7.7.2 Harbin Pharmaceutical Group Swine Mycoplasma Vaccine Product Portfolio
7.7.3 Harbin Pharmaceutical Group Swine Mycoplasma Vaccine Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Harbin Pharmaceutical Group Main Business and Markets Served
7.7.5 Harbin Pharmaceutical Group Recent Developments/Updates
7.8 Pulike Biotech
7.8.1 Pulike Biotech Swine Mycoplasma Vaccine Corporation Information
7.8.2 Pulike Biotech Swine Mycoplasma Vaccine Product Portfolio
7.8.3 Pulike Biotech Swine Mycoplasma Vaccine Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Pulike Biotech Main Business and Markets Served
7.7.5 Pulike Biotech Recent Developments/Updates
7.9 Qilu Animal Health Products
7.9.1 Qilu Animal Health Products Swine Mycoplasma Vaccine Corporation Information
7.9.2 Qilu Animal Health Products Swine Mycoplasma Vaccine Product Portfolio
7.9.3 Qilu Animal Health Products Swine Mycoplasma Vaccine Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Qilu Animal Health Products Main Business and Markets Served
7.9.5 Qilu Animal Health Products Recent Developments/Updates
7.10 Wuhan Keqian Biology
7.10.1 Wuhan Keqian Biology Swine Mycoplasma Vaccine Corporation Information
7.10.2 Wuhan Keqian Biology Swine Mycoplasma Vaccine Product Portfolio
7.10.3 Wuhan Keqian Biology Swine Mycoplasma Vaccine Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Wuhan Keqian Biology Main Business and Markets Served
7.10.5 Wuhan Keqian Biology Recent Developments/Updates
7.11 Guangdong Winsun Bio-Pharmaceutical
7.11.1 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Vaccine Corporation Information
7.11.2 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Vaccine Product Portfolio
7.11.3 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Vaccine Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Guangdong Winsun Bio-Pharmaceutical Main Business and Markets Served
7.11.5 Guangdong Winsun Bio-Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Swine Mycoplasma Vaccine Industry Chain Analysis
8.2 Swine Mycoplasma Vaccine Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Swine Mycoplasma Vaccine Production Mode & Process
8.4 Swine Mycoplasma Vaccine Sales and Marketing
8.4.1 Swine Mycoplasma Vaccine Sales Channels
8.4.2 Swine Mycoplasma Vaccine Distributors
8.5 Swine Mycoplasma Vaccine Customers
9 Swine Mycoplasma Vaccine Market Dynamics
9.1 Swine Mycoplasma Vaccine Industry Trends
9.2 Swine Mycoplasma Vaccine Market Drivers
9.3 Swine Mycoplasma Vaccine Market Challenges
9.4 Swine Mycoplasma Vaccine Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Zoetis
Boehringer Ingelheim
Jinhe Biotechnology
Merck
HIPRA
Ceva Sant茅 Animale
Harbin Pharmaceutical Group
Pulike Biotech
Qilu Animal Health Products
Wuhan Keqian Biology
Guangdong Winsun Bio-Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂